Answer
Cytarabine is converted to ARA-CTP, which competitively inhibits DNA polymerase, and acts as a false nucleoside, competing for enzymes involved in converting cytidine nucleotide to deoxycytidine nucleotide and for incorporation into DNA.
Sources for this answer
- Cytarabine Injection Solution 100 mg/mlHospira UK Ltd · emc · SmPC §5.1 Pharmacodynamic properties · Version 21Document updated
Sources checked